BRUNETTI, JLENIA
 Distribuzione geografica
Continente #
EU - Europa 6.225
NA - Nord America 6.062
AS - Asia 2.538
SA - Sud America 386
AF - Africa 32
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 3
Totale 15.258
Nazione #
US - Stati Uniti d'America 5.989
GB - Regno Unito 1.330
IT - Italia 1.297
RU - Federazione Russa 1.275
CN - Cina 937
SG - Singapore 772
IE - Irlanda 718
SE - Svezia 372
BR - Brasile 319
DE - Germania 316
UA - Ucraina 275
HK - Hong Kong 196
FR - Francia 191
KR - Corea 162
VN - Vietnam 154
FI - Finlandia 140
IN - India 95
ES - Italia 70
BE - Belgio 52
PL - Polonia 42
CA - Canada 40
BD - Bangladesh 34
NL - Olanda 33
AR - Argentina 28
AT - Austria 26
TR - Turchia 26
IR - Iran 22
JP - Giappone 21
MX - Messico 21
CZ - Repubblica Ceca 20
PK - Pakistan 17
CH - Svizzera 16
IQ - Iraq 13
IL - Israele 11
PH - Filippine 11
AE - Emirati Arabi Uniti 10
EC - Ecuador 10
ZA - Sudafrica 10
AU - Australia 9
LT - Lituania 9
ID - Indonesia 7
PE - Perù 7
RO - Romania 7
VE - Venezuela 7
BG - Bulgaria 6
CI - Costa d'Avorio 6
CL - Cile 6
AZ - Azerbaigian 5
DK - Danimarca 5
EE - Estonia 5
KZ - Kazakistan 5
CO - Colombia 4
DZ - Algeria 4
EG - Egitto 4
JO - Giordania 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
AM - Armenia 3
EU - Europa 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
MA - Marocco 3
NP - Nepal 3
NZ - Nuova Zelanda 3
RS - Serbia 3
AL - Albania 2
BB - Barbados 2
BY - Bielorussia 2
CR - Costa Rica 2
CY - Cipro 2
LV - Lettonia 2
PA - Panama 2
PT - Portogallo 2
PY - Paraguay 2
QA - Qatar 2
SI - Slovenia 2
TH - Thailandia 2
TJ - Tagikistan 2
TN - Tunisia 2
TW - Taiwan 2
UY - Uruguay 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CM - Camerun 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
JM - Giamaica 1
MM - Myanmar 1
MT - Malta 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
Totale 15.254
Città #
Southend 1.208
Dallas 814
Dublin 708
Fairfield 567
Ashburn 481
Singapore 461
Chandler 402
Siena 395
Moscow 367
Santa Clara 286
Woodbridge 277
Ann Arbor 272
Beijing 265
Houston 228
Seattle 226
Jacksonville 222
Wilmington 202
Hong Kong 189
Hefei 180
Menlo Park 171
Seoul 162
Cambridge 159
New York 111
Milan 108
Princeton 104
Los Angeles 101
Florence 86
Munich 81
Dong Ket 70
Nanjing 69
Rome 65
Boardman 64
Helsinki 60
Málaga 48
Council Bluffs 39
San Diego 39
Shanghai 39
Fremont 37
Brussels 36
The Dalles 36
Bengaluru 35
Dearborn 32
Buffalo 31
Nanchang 31
San Mateo 30
Ho Chi Minh City 28
London 28
Hebei 26
Columbus 25
São Paulo 25
Turku 23
Shenyang 22
Warsaw 22
Washington 22
Bagno a Ripoli 21
Chicago 21
Hanoi 20
Lappeenranta 20
Atlanta 18
Redondo Beach 18
Tianjin 18
Brooklyn 17
Tokyo 17
Vienna 17
Brno 16
Düsseldorf 16
Phoenix 16
Redwood City 15
Stockholm 15
Gdansk 14
Naples 14
Frankfurt am Main 13
Kunming 13
Nuremberg 13
Toronto 13
Chennai 12
Rio de Janeiro 12
San Francisco 12
Izmir 11
Montreal 11
Denver 10
Dhaka 10
Guangzhou 10
Johannesburg 9
Poplar 9
Portsmouth 9
Changsha 8
Jiaxing 8
Jinan 8
Ningbo 8
Orem 8
Arezzo 7
Barcelona 7
Brasília 7
Campinas 7
Colle Di Val D'elsa 7
Ghent 7
Hangzhou 7
Manila 7
Mexico City 7
Totale 10.378
Nome #
Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging 351
Insights into the role of sulfated glycans in cancer cell adhesion and migration through use of branched peptide probe 342
The GAG-specific branched peptide NT4 reduces angiogenesis and invasiveness of tumor cells 341
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients 323
Investigations into the killing activity of an antimicrobial peptide active against extensively antibiotic-resistant K. pneumoniae and P. aeruginosa 321
Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System 321
Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug 304
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo. 304
Heparan sulfate proteoglycans can promote opposite effects on adhesion and directional migration of different cancer cells 299
Cancer selectivity of tetrabranched neurotensin peptides is generated by simultaneous binding to sulfated glycosaminoglycans and protein receptors. 288
An antimicrobial molecule mitigates signs of sepsis in vivo and eradicates infections from lung tissue 285
Efficacy and toxicity of the antimicrobial peptide M33 produced with different counter-ions 280
A CVID-associated variant in the ciliogenesis protein CCDC28B disrupts immune synapse assembly 280
A new NT4 peptide-based drug delivery system for cancer treatment 279
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo 278
Neurotensin branched peptide as a tumor-targeting agent for human bladder cancer 278
The proteome speciation of an immortalized cystic fibrosis cell line: New perspectives on the pathophysiology of the disease 272
Unraveling Heparan Sulfate Proteoglycan Binding Motif for Cancer Cell Selectivity 272
A novel phage-library-selected peptide inhibits human TNF-α binding to its receptors 263
In vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate 258
Oxidative stress-induced apoptosis in peripheral blood lymphocytes from patients with POLG-related disorders 258
Coupling to a cancer-selective heparan-sulfate-targeted branched peptide can by-pass breast cancer cell resistance to methotrexate 257
Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens 257
Site-specific pegylation of an antimicrobial peptide increases resistance to Pseudomonas aeruginosa elastase 246
Antimicrobial peptide-loaded nanoparticles as inhalation therapy for Pseudomonas aeruginosa infections 246
Antibacterial and anti-inflammatory activity of an antimicrobial peptide synthesized with D amino acids 245
Branched peptides as bioactive molecules for drug design 239
Modular Branched Neurotensin Peptides for Tumor Target Tracing and Receptor-Mediated Therapy: A Proof-of-Concept 226
Antibacterial and Anti-Inflammatory Activity of Branched Peptides Derived from Natural Host Defense Sequences 223
Nanoparticles exposing neurotensin tumor-specific drivers 219
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 217
Branched peptides as targeting agents for tumor imaging and therapy 215
Dendrimeric peptide inhibitors of anthrax lethal and edema factors 208
Antimicrobial peptides active in in vitro models of endodontic bacterial infections modulate inflammation in human cardiac fibroblasts 205
Branched Neurotensin peptides for tumor personalized therapy 203
Immunomodulatory and anti-inflammatory activity in vitro and in vivo of a novel antimicrobial candidate 202
A selective Nile Red based solvatochromic probe: A study of fluorescence in LUVs and GUVs model membranes 200
Exploiting Free-Energy Minima to Design Novel EphA2 Protein-Protein Antagonists: From Simulation to Experiment and Return 199
Synthesis and biological activity of stable branched neurotensin peptides for tumor targeting 199
Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens 199
Targeting different LRP receptors and sulfated proteoglycan by branched neurotensin provide high cancer selectivity 198
Analysis of opa1 isoforms expression and apoptosis regulation in autosomal dominant optic atrophy (ADOA) patients with mutations in the opa1 gene 196
Turning nonspecific cytotoxic drugs into tumor-selective agents via conjugation to branched peptides. 194
Endocytosis and trafficking of heparan sulfate proteoglycans in triple-negative breast cancer cells unraveled with a polycationic peptide 194
Design and in vitro evaluation of branched peptide conjugates:turning nonspecific cytotoxic drugs into tumor-selective agents 193
The antimicrobial peptide M33. An example of drug development 189
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 187
Biochemical characterization and strong in vivo activity of a novel antimicrobial peptide specific for gram-negative bacteria 182
Molecular definition of the interaction between a tumor-specific tetrabranched peptide and LRP6 receptor 181
Light-Switchable Membrane Permeability in Giant Unilamellar Vesicles 180
Tumor selective targeting by branched peptides 179
Dendrimeric peptide inhibitors of anthrax lethal and edema factor 167
NMR study of the secondary structure and biopharmaceutical formulation of an active branched antimicrobial peptide 167
Increasing LFA-1 Expression Enhances Immune Synapse Architecture and T Cell Receptor Signaling in Jurkat E6.1 Cells 167
The Bardet-Biedl syndrome complex component BBS1 controls T cell polarity during immune synapse assembly 167
The Intraflagellar Transport Protein IFT20 Recruits ATG16L1 to Early Endosomes to Promote Autophagosome Formation in T Cells 166
null 165
The antimicrobial peptide M33. An example of drug development 156
Target Selective Drug Delivery through Liposome Labeled with Oligobranched Neurotensin Peptides 150
Solubility improvement of an anthrax toxin peptide inhibitor by rational aminoacid randomization 147
Branched oncolytic peptides target HSPGs, inhibit metastasis, and trigger the release of molecular determinants of immunogenic cell death in pancreatic cancer 146
Structural and antigen-binding surface definition of an anti-CD93 monoclonal antibody for the treatment of degenerative vascular eye diseases 146
Stable peptide inhibitors prevent binding of lethal and oedema factors to protective antigen and neutralize anthrax toxin in vivo 142
Safety evaluations of a synthetic antimicrobial peptide administered intravenously in rats and dogs 131
Modelling PCDH19 clustering epilepsy by Neurogenin 2 induction of patient-derived induced pluripotent stem cells 128
The tardigrade damage suppressor protein modulates transcription factor and DNA repair genes in human cells treated with hydroxyl radicals and UV-C 127
In Vivo Efficacy and Toxicity of an Antimicrobial Peptide in a Model of Endotoxin-Induced Pulmonary Inflammation 125
Inhalable Polymeric Nanoparticles for Pulmonary Delivery of Antimicrobial Peptide SET-M33: antibacterial activity and toxicity in vitro and in vivo 121
Targeting heparan sulfate proteoglycans as an effective strategy for inhibiting cancer cell migration and invasiveness compared to heparin 120
Turning Traditional Cytotoxic Drugs Into Tumour-selective Agents 115
null 105
null 78
Models of in-vivo Bacterial Infections for the Development of Antimicrobial Peptide-Based Drugs 65
Editorial: Proteoglycans in the Tumor Microenvironment 48
Totale 15.524
Categoria #
all - tutte 47.794
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.794


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.277 0 0 0 0 0 198 201 214 119 283 106 156
2021/20221.157 71 98 65 100 99 61 57 66 57 145 129 209
2022/20231.493 76 155 180 194 170 248 45 133 111 66 68 47
2023/20241.317 39 33 108 84 75 366 414 35 10 33 30 90
2024/20252.511 77 100 309 125 305 145 116 183 195 92 268 596
2025/20263.915 436 745 718 767 1.201 48 0 0 0 0 0 0
Totale 15.524